ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,634Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 1844

$936K Total Retail Price of All Prescriptions

Rank: 63 out of 1844

413 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

14% of this provider’s 413 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 6,436 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 600 321 1 1
OMEPRAZOLE 434 155 2 5
POLYETHYLENE GLYCOL 3350 349 66 3 39
LISINOPRIL 329 200 4 4
SIMVASTATIN 308 196 5 3
METOPROLOL TARTRATE 251 203 6 11
METFORMIN HCL 249 106 7 8
HYDROCODONE-ACETAMINOPHEN 224 152 S3 8 2
FUROSEMIDE 204 139 9 7
AMLODIPINE BESYLATE 193 151 10 6
RISPERIDONE 182 21 11 65
ALENDRONATE SODIUM 181 76 12 25
CHLORHEXIDINE GLUCONATE 177 13 13 229
SERTRALINE HCL 168 88 14 21
METOPROLOL SUCCINATE 161 115 15 14
POTASSIUM CHLORIDE 158 112 16 16
CLOPIDOGREL 154 124 17 34
PANTOPRAZOLE SODIUM 149 95 18 32
NEXIUM 133 42 19 31
RANITIDINE HCL 131 37 20 38
ATENOLOL 124 88 21 17
ATORVASTATIN CALCIUM 124 56 21 12
PLAVIX 115 92 23 61
FLUOXETINE HCL 107 40 24 41
PRAVASTATIN SODIUM 104 82 25 10
TRIAMTERENE-HCTZ 103 86 26 48
CYMBALTA 96 42 27 36
GABAPENTIN 96 29 27 15
ISOSORBIDE MONONITRATE ER 94 93 29 59
TRAMADOL HCL 93 64 30 18
FLUTICASONE PROPIONATE 93 27 30 50
FAMOTIDINE 90 59 32 63
ABILIFY 88 0 33 150
MELOXICAM 86 29 34 28
VENLAFAXINE HCL ER 83 53 35 93
PAROXETINE HCL 83 15 35 68
METFORMIN HCL ER 82 56 37 46
TRAZODONE HCL 82 19 37 43
LAMOTRIGINE 75 13 39 174
SPIRIVA 73 43 40 57
ROPINIROLE HCL 72 49 41 76
CITALOPRAM HBR 70 19 42 19
LOSARTAN POTASSIUM 69 64 43 24
ZOLPIDEM TARTRATE 68 57 44 23
SYNTHROID 66 64 45 55
LEVETIRACETAM 66 13 45 105
ALLOPURINOL 63 38 47 29
DIVALPROEX SODIUM ER 62 13 48 180
OLANZAPINE 62 41 48 117
TAMSULOSIN HCL 61 41 50 27
OXYBUTYNIN CHLORIDE 61 32 50 103
LOPERAMIDE 61 13 50 216
CARBAMAZEPINE 60 0 53 204
KETOCONAZOLE 58 20 54 231
LANTUS 55 41 55 42
NAMENDA 55 34 55 33
KLOR-CON M10 53 15 57 149
HYDROCHLOROTHIAZIDE 53 37 57 9
LOSARTAN-HYDROCHLOROTHIAZIDE 52 33 59 47
LYRICA 52 41 59 92
AMITRIPTYLINE HCL 52 20 R 59 72
CRESTOR 50 25 62 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.